Gene-environmental effects behind leukoaraiosis: a silent genetic variant of the kinesin protein can be activated in a subject with poorly controlled long-lasting hypertension

Clinical Biochemistry

Volumn 42, Issue 7-8, 2009, Pages 630-633

  Szolnoki, Zoltan ^a   Kondacs, Andras ^a   Mandi, Yvette ^b   Somogyvari, Ferenc ^b  

^a Pandy Kalman Bekes County Hospital   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Gene; Gene environmental interaction; Genetic variant; Kinesin; Leukoaraiosis; White matter damage

Indexed keywords

KINESIN;

AGED; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE ACTIVATION; GENE AMPLIFICATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERTENSION; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; KINESIN; LEUKOARAIOSIS; MALE; MIDDLE AGED;

EID: 63649091664     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.11.003     Document Type: Article

References (27)

1. Hachinski V.C., Potter P., and Merskey H. Leuko-araiosis: an ancient term for a new problem. Can. J. Neurol. Sci. 13 (1986) 533-534
2. Pantoni L., and Garcia J.H. Pathogenesis of leukoaraiosis, a review. Stroke 28 (1997) 652-659
3. Pantoni L. Pathophysiology of age-related cerebral white matter changes. Cerebrovasc. Dis. 13 suppl. 2 (2002) 7-14
4. Steingart A., Hachinski V.C., Lau C., et al. Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch. Neurol. 44 (1987) 32-35
5. Steingart A., Hachinski V.C., Lau C., et al. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch. Neurol. 44 (1987) 36-39
6. Basile A.M., Pantoni L., Pracucci G., et al. (2006) Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) study. Cerebrovasc. Dis. 2 (2006) 315-322
7. Yao H., Sadoshima S., Ibayashi S., Kuwabara Y., Ichiya Y., and Fujishima M. Leukoaraiosis and dementia in hypertensive patients. Stroke 23 (1992) 1673-1677
8. Ylikoski R., Ylikoski A., Erkinjuntti T., et al. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch. Neurol. 50 (1993) 818-824
9. Inzitari D., Simoni M., Pracucci G., et al. Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch. Intern. Med. 167 (2007) 81-88
10. Junque C., Pujol J., Vendrell P., et al. Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Arch. Neurol. 47 (1990) 151-156
11. Liu C.K., Miller B.L., Cummings J.L., et al. A quantitative MRI study of vascular dementia. Neurology 42 (1992) 138-143
12. van Gijn J. Leukoaraiosis and vascular dementia. Neurology 51 (1998) 3-8
13. Szolnoki Z. Chemical events behind leukoaraiosis: medicinal chemistry offers a new insight into a specific microcirculation disturbance in the brain (a chemical approach to a frequent cerebral phenotype). Curr. Med. Chem. 14 (2007) 1027-1236
14. Brown W.R., Moody D.M., Thore C.R., Challa V.R., and Anstrom J.A. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. J. Neurol. Sci. 257 (2007) 62-66
15. Wardlaw J.M., Sandercock P.A., Dennis M.S., and Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?. Stroke 34 (2003) 806-812
16. Fornage M., Mosley T.H., Jack C.R., et al. Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury. Hum. Genet. 120 (2007) 671-680
17. Szolnoki Z. Pathomechanism of leukoaraiosis: a molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis). Neuromol. Med. 9 (2007) 21-33
18. Szolnoki Z., Kondacs A., Mandi Y., and Somogyvari F. A genetic variant in cytoskeleton motors amplifies susceptibility to leukoaraiosis in hypertensive smokers: gene-environmental interactions behind vascular white matter demyelinization. J. Mol. Neurosci. 33 2 (2007) 173-179
19. Carson J.H., Worboys K., Ainger K., et al. Translocation of myelin basic protein mRNA in oligodendrocytes requires microtubulus and kinesin. Cell. Motil. Cytoskel. 38 (1997) 318-328
20. Szolnoki Z., Somogyvari F., Kondacs A., Szabo M., and Fodor L. Evaluation of the roles of common genetic mutations in leukoaraiosis. Acta Neurol. Scand. 104 (2001) 281-287
21. Fazekas F., Chawluk J.B., Alavi A., et al. MRI signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am. J. Roentgenol. 149 (1987) 351-356
22. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16 (1988) 1215-1218
23. Dhaenens C.M., Van Brussel E., Schraen-Maschke S., Pasquier F., Delacourte A., and Sablonniere B. Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease. Neurosci. Lett. 368 (2004) 290-292
24. Andersson M.E., Sjölander A., Andreasen N., et al. Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease. Int. J. Mol. Med. 20 (2007) 233-239
25. Andersson M.E., Zetterberg M., Tasa G., et al. Variability in the kinesin light chain 1 gene may influence risk of age-related cataract. Mol. Vis. 13 (2007) 993-996
26. Szolnoki Z., Kondacs A., Mandi Y., and Somogyvari F. A cytoskeleton motor protein genetic variant may exert a protective effect on the occurrence of multiple sclerosis: the Janus face of the kinesin light chain 1 56836CC variant. Neuromolecular Med. 9 4 (2007) 335-339
27. Szolnoki Z. Genetic variant-associated endothelial dysfunction behind small-vessel cerebral circulatory disorders: a new pathomechanism behind common cerebral phenotypes (Review). Mini Rev. Med. Chem. 7 (2007) 527-530